A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2006
11/23/2006	WO2006074278A3 Compositions for treating diabetes or obesity
11/23/2006	WO2006071762A3 Pyrimidine-based inhibitors of dipeptidyl peptidase iv and methods
11/23/2006	WO2006071538A3 Substituted biaryl analogues
11/23/2006	WO2006067465A3 Cancer treatment
11/23/2006	WO2006061372A3 Phenylpiperazines with a combination of affinity for dopamine -d2 receptors and serotonin reuptake sites
11/23/2006	WO2006049813A3 Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
11/23/2006	WO2006044449A3 Cgrp receptor antagonists
11/23/2006	WO2006040688B1 Inhibitors of acetylcholinesterase for treating skin diseases
11/23/2006	WO2006034001A3 Methods of treating hiv infection
11/23/2006	WO2006033081A3 Peroxisome proliferation receptor agonists, for the treatment of gastritis
11/23/2006	WO2006031706A3 Betulinol derivatives as anti-hiv agents
11/23/2006	WO2006029154A3 Novel compounds
11/23/2006	WO2006025859A3 Methods, compositions, and apparatuses for forming macrocyclic compounds
11/23/2006	WO2006007136B1 Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease
11/23/2006	WO2005121139A8 Substituted tricyclic benzimidazoles
11/23/2006	WO2005115403A3 Induction of innate immunity by vitamin d3 and its analogs
11/23/2006	WO2005112941A3 Substituted cyclic urea derivatives
11/23/2006	WO2005112932A3 Raf modulators and methods of use
11/23/2006	WO2005110473A3 Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
11/23/2006	WO2005107461A8 Modulating lymphatic function
11/23/2006	WO2005077050A3 Hiv integrase inhibitors
11/23/2006	WO2005074995A3 Combined use of prame inhibitors and hdac inhibitors
11/23/2006	WO2005062739A3 S-allylmercaptocysteine prodrugs and methods of treatment
11/23/2006	WO2005000224A3 Novel dermatological composition
11/23/2006	WO2004103272A3 Improved cytotoxic agents comprising new maytansinoids
11/23/2006	WO2004066863A3 Immunopotentiating agent for use in animals
11/23/2006	US20060265779 Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors
11/23/2006	US20060265763 Dyrks as modifiersof the apc and axin pathways and methods of use
11/23/2006	US20060264653 Aminoacetonitrile derivatives and their use for controlling parasites
11/23/2006	US20060264639 crystalline rosiglitazone maleate filtration
11/23/2006	US20060264638 Useful in the treatment of chronic and acute pain; 1-[4-dibenzocycloheptyl-4-piperidinyl]-1,3-dihydro-2H-1,3-benzamidazol-2-one;
11/23/2006	US20060264636 Salts of clopidogrel and process for preparation
11/23/2006	US20060264630 Antidiabetic agents; modulate insulin drug resistance
11/23/2006	US20060264628 Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases
11/23/2006	US20060264627 Heterocyclic hydrazones as novel anti-cancer agents
11/23/2006	US20060264626 INHIBITORS OF FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE
11/23/2006	US20060264609 Use of heat shock proteins
11/23/2006	US20060264517 Methods of reducing microbial resistance to drugs
11/23/2006	US20060264516 Use of low molecular weight amino alcohols in ophthalmic compositions
11/23/2006	US20060264515 Compounds, formulations, and methods for ameliorating telangiectasias
11/23/2006	US20060264514 4-oxo-fenretinide, administered alone and in combination with fenretinide, as preventive and therapeutic agent for cancer
11/23/2006	US20060264513 Phenoxy carboxylic acid compounds and compositions for delivering active agents
11/23/2006	US20060264512 Method for the treatment of sexual dysfunction due to medical conditions
11/23/2006	US20060264511 Method for the treatment of drug-induced sexual dysfunction
11/23/2006	US20060264510 Antiviral methods and compositions
11/23/2006	US20060264509 Methods for treating pain using smooth muscle modulators and a2 subunit calcium channel modulators
11/23/2006	US20060264508 Modulation of ocular growth and myopia by gaba drugs
11/23/2006	US20060264507 Formoterol tartrate process and polymorph
11/23/2006	US20060264506 Meldonium salts, method of their preparation and pharmaceutical composition on their basis
11/23/2006	US20060264505 Dermatological compositions
11/23/2006	US20060264504 Treatment of cell-mediated immune diseases
11/23/2006	US20060264503 Treating pain using selective antagonists of persistent sodium current
11/23/2006	US20060264502 Agent for treatment of cisplatin-resistant cancer
11/23/2006	US20060264501 For parenteral administration containing oxaliplatin, water; and an acid, especially a di- or tricarboxylic acid such as tartaric acid or a sodium tartrate as a buffering agent that minimises significant degradation of oxaliplatin and limits the formation of unwanted impurities; cancer treatment
11/23/2006	US20060264500 e.g. 2-(3,4,5-TRIMETHOXYPHENYL)-3,4-DIHYDRO-2H-BENZO[H]CHROMEN-4-OL; stimulating the endogenous production of a metalloproteinase inhibitor; useful for treating cancer of the brain, breast, ovary, prostate, lung, kidney or colon
11/23/2006	US20060264499 Novel biologically active lasonolide compounds
11/23/2006	US20060264498 Anti-obesity agent
11/23/2006	US20060264497 Diindolylmethane-based compositions and methods of use thereof for promoting oral mucosal and bone health
11/23/2006	US20060264496 Substituted indoline and indole derivatives
11/23/2006	US20060264495 Methods of using [3.2.0] heterocyclic compounds and analogs thereof
11/23/2006	US20060264494 Heterocyclic amide derivatives which process glycogen phorylase inhibitory activity
11/23/2006	US20060264493 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/23/2006	US20060264492 methyl [5(6)-(4-alanylaminophenylthio)-1H-benzimidazol-2yl]carbamate; for treating neovascularization, solid tumors, macular degeneration, diabetic retinopathy, rheumatoid arthritis, psoriasis, and atherosclerosis
11/23/2006	US20060264491 Telmisartan production process
11/23/2006	US20060264490 Compounds, Compositions Containing Them, Preparation Thereof and Uses Thereof I
11/23/2006	US20060264488 Tubular proteinuria as an indicator for elevated cardiovascular risk
11/23/2006	US20060264487 Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles
11/23/2006	US20060264486 (5-{3-[4-(4,5,6,7-tetrahydro-benzooxazol-2-yl)-phenoxy]-propoxy}-indol-1-yl)-acetic acid; diabetes, obesity, hyperlipidemia, and atherosclerotic disease
11/23/2006	US20060264485 Pro-drugs of N-thiazol-2-yl-benzamide derivatives
11/23/2006	US20060264484 Fc receptor modulating compounds and compositions
11/23/2006	US20060264483 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
11/23/2006	US20060264482 Epothilones C, D, E and F, preparation and compositions
11/23/2006	US20060264481 Therapeutic modulation of PPARgamma activity
11/23/2006	US20060264480 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
11/23/2006	US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors
11/23/2006	US20060264478 Methods and compositions for modulating calcium channels
11/23/2006	US20060264477 Methods of using cyclic amides
11/23/2006	US20060264476 Substituted imidazoles and thiazoles; 4-(((6-chloro-2-(3-chlorophenyl)-3-pyridinyl)methoxy)(1-methyl-1H-imidazol-5-yl)methyl)benzonitrile, antitumor agents
11/23/2006	US20060264475 Compounds, compositions and methods for inhibiting or treating hiv-1
11/23/2006	US20060264474 novel sulphonamide, sulphamate and sulphamide derivatives, comprising a m-disubstituted benzene or pyridine ring and a substituted pyrazole moiety, which inhibit the processing of APP by gamma -secretase, and hence are useful in the treatment or prevention of Alzheimer's disease
11/23/2006	US20060264473 3-(4-Benzyloxy-3-methoxy-phenyl)-3-methoxy-2-(2-pyridin-2-yl-ethyl)-2,3-dihydro-isoindol-1-one; viricides; anticarcinogenic agents
11/23/2006	US20060264472 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a] IMIDAZOLE-3-SULFONIC ACID
11/23/2006	US20060264471 3-(cyclopenten-1-yl)-benzyl-or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derviatives and use thereof as medicines for treating schizophrenia
11/23/2006	US20060264470 e.g. 4-(4-chlorophenyl)-5-(2,4-dichlorophenyl)-3-methyl-N-piperidin-1-ylthiophene-2-carboxamide; cannabinoid receptor antagonist; antiinflammatory agent; obesity, gastrointestinal disorders, inflammatory phenomena, immune system diseases, psychotic disorders, alcohol and nicotine dependence
11/23/2006	US20060264469 Pharmaceutical composition for oral administration of a pyrazole-3-carboxamide derivative
11/23/2006	US20060264468 Use of substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections
11/23/2006	US20060264467 Method for the treatment of Pompe disease using 1-deoxynojirimycin and derivatives
11/23/2006	US20060264466 N-(1-methylpiperidin-4-yl)-N-(4-flourophenylmethyl)-N-'-(4-(2-methylpropyloxy)phenylmethyl)carbamide ; antipsychotic and anti-dyskinetic; use as novel therapeutics, sometimes in conjunction with other therapeutics, for Parkinson's Disease, related human neurodegenerative diseases, and psychosis
11/23/2006	US20060264465 N-(1-methylpiperidin-4-yl)-N-(4-flourophenylmethyl)-N-'-(4-(2-methylpropyloxy)phenylmethyl)carbamide ; antipsychotic and anti-dyskinetic; use as novel therapeutics, sometimes in conjunction with other therapeutics, for Parkinson's Disease, related human neurodegenerative diseases, and psychosis
11/23/2006	US20060264464 Amidino compounds as cysteine protease inhibitors
11/23/2006	US20060264463 Chemical compounds
11/23/2006	US20060264462 Imidazolamino compounds
11/23/2006	US20060264461 Imidazolamino compounds
11/23/2006	US20060264460 3-Cyanoquinoline inhibitors of Tpl2 kinase and methods of making and using the same
11/23/2006	US20060264459 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
11/23/2006	US20060264458 Quinine dosage forms and methods of use thereof
11/23/2006	US20060264456 Phosphorus-containing compounds & uses thereof
11/23/2006	US20060264455 Use of huperzine for disorders
11/23/2006	US20060264454 Use of huperzine for neuropathic pain
11/23/2006	US20060264453 Rapamycin formulations and methods of their use

1 ... 3994 3995 3996 3997 3998 3999 4000 4001 4002 4003 4004 4005 4006 4007 4008 4009 4010 4011 4012 4013 4014 ... 7860